Milestone Scientific Inc ( (MLSS) ) has released its Q2 earnings. Here is a breakdown of the information Milestone Scientific Inc presented to its investors.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Milestone Scientific Inc., a Delaware-based company, specializes in developing computer-controlled anesthetic delivery devices for dental and medical applications, with a focus on innovative technology in the healthcare sector. In its latest earnings report for the quarter ended June 30, 2025, Milestone Scientific Inc. highlighted a net loss of $1.48 million, compared to a net income of $223,638 in the same quarter of the previous year. The company reported product sales of $2.32 million, a notable increase from $1.85 million in the same period last year, driven by a rise in dental segment sales. Despite an increase in gross profit to $1.62 million, the company faced higher operating expenses, which contributed to the overall loss. Milestone Scientific’s financial performance was impacted by increased selling, general, and administrative expenses, as well as research and development costs. The company continues to face challenges related to its cash flow and liquidity, with cash and cash equivalents decreasing to $1.27 million from $3.26 million at the end of 2024. Looking ahead, Milestone Scientific’s management remains focused on securing additional funding to support its operations and aims to enhance revenue generation from its dental and medical device segments, while also working to reduce operating expenses.